These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7603135)

  • 1. [Opsonizing activity of human immunoglobulin preparations for intravenous use (IVIG)].
    Banach W; Bucholc B
    Med Dosw Mikrobiol; 1994; 46(4):349-55. PubMed ID: 7603135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulin M-enriched intravenous immunoglobulin inhibits classical pathway complement activation, but not bactericidal activity of human serum.
    Walpen AJ; Laumonier T; Aebi C; Mohacsi PJ; Rieben R
    Xenotransplantation; 2004 Mar; 11(2):141-8. PubMed ID: 14962276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antibody activity against various microorganisms in intravenous immunoglobulin preparations determined by ELISA and opsonic assay.
    Hiemstra PS; Brands-Tajouiti J; van Furth R
    J Lab Clin Med; 1994 Feb; 123(2):241-6. PubMed ID: 8301200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyvalent immunoglobulin significantly attenuated the formation of IL-1β in Escherichia coli-induced sepsis in pigs.
    Barratt-Due A; Sokolov A; Gustavsen A; Hellerud BC; Egge K; Pischke SE; Lindstad JK; Pharo A; Castellheim A; Thorgersen EB; Mollnes TE
    Immunobiology; 2013 May; 218(5):683-9. PubMed ID: 22947599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dose intravenous immunoglobulin does not affect complement-bacteria interactions.
    Wagner E; Platt JL; Frank MM
    J Immunol; 1998 Feb; 160(4):1936-43. PubMed ID: 9469456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo activity of hyperimmune globulin preparations against multiresistant nosocomial pathogens.
    Rossmann FS; Kropec A; Laverde D; Saaverda FR; Wobser D; Huebner J
    Infection; 2015 Apr; 43(2):169-75. PubMed ID: 25428225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients.
    Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED
    J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antibacterial activity of tramadol against bacteria associated with infectious complications after local or regional anesthesia.
    Tamanai-Shacoori Z; Shacoori V; Jolivet-Gougeon A; Vo Van JM; Repère M; Donnio PY; Bonnaure-Mallet M
    Anesth Analg; 2007 Aug; 105(2):524-7. PubMed ID: 17646517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin M-enriched human intravenous immunoglobulin prevents complement activation in vitro and in vivo in a rat model of acute inflammation.
    Rieben R; Roos A; Muizert Y; Tinguely C; Gerritsen AF; Daha MR
    Blood; 1999 Feb; 93(3):942-51. PubMed ID: 9920844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement-mediated bactericidal effect of antibodies in human intravenous preparation against multi-drug resistant pseudomonas aeruginosa.
    Nakae T; Tanaka J; Nakano A; Ono Y
    Jpn J Antibiot; 2008 Dec; 61(6):379-87. PubMed ID: 19288855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonic activity of commercially available standard intravenous immunoglobulin preparations.
    Weisman LE; Cruess DF; Fischer GW
    Pediatr Infect Dis J; 1994 Dec; 13(12):1122-5. PubMed ID: 7892082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravenous immunoglobulin G on the deposition of immunoglobulin G and C3 onto type III group B streptococcus and Escherichia coli K1.
    Lassiter HA; Robinson TW; Brown MS; Hall DC; Hill HR; Christensen RD
    J Perinatol; 1996; 16(5):346-51. PubMed ID: 8915932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An experimental study on antimicrobial activity of silicone oil in vitro.
    Yan H; Li J
    Ophthalmologica; 2008; 222(4):245-8. PubMed ID: 18467849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of a micromethod for the bactericidal activity of five disinfectants on 108 hospital strains].
    Dusseau JY; Chapalain JC; Rouby Y; Reverdy ME; Bartoli M
    Pathol Biol (Paris); 1993 Apr; 41(4):349-57. PubMed ID: 8233634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
    Cetinkaya E; Coban AY; Durupinar B
    Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of Staphylococcus aureus Panton Valentine leukocidin by intravenous immunoglobulin in vitro.
    Gauduchon V; Cozon G; Vandenesch F; Genestier AL; Eyssade N; Peyrol S; Etienne J; Lina G
    J Infect Dis; 2004 Jan; 189(2):346-53. PubMed ID: 14722901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of antibacterial and antitoxic activity of normal human immunoglobulin for intravenous use (IVIG)].
    Bucholc B; Banach W; Wysokińska T; Cieślik A; Chodorowska M
    Med Dosw Mikrobiol; 1996; 48(1-2):87-94. PubMed ID: 8926773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antibacterial effects of topical local anesthetics.
    Sedef Gocmen J; Buyukkocak U; Caglayan O; Aksoy A
    J Dermatolog Treat; 2008; 19(6):351-3. PubMed ID: 18608709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
    Pollreisz A; Assinger A; Hacker S; Hoetzenecker K; Schmid W; Lang G; Wolfsberger M; Steinlechner B; Bielek E; Lalla E; Klepetko W; Volf I; Ankersmit HJ
    Br J Dermatol; 2008 Sep; 159(3):578-84. PubMed ID: 18565176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.